Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators; Khosravi, Mohammadhossein
Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Cause of Death/trends; Child; Child, Preschool; Communicable Diseases/mortality; Disabled Persons/statistics & numerical data; Female; Global Burden of Disease/statistics & numerical data; Global Health/statistics & numerical data; Humans; Incidence; Infant; Infant, Newborn; Male; Middle Aged; Noncommunicable Diseases/mortality; Prevalence; Sex Distribution; Wounds and Injuries/mortality; Young Adult; Cause of Death; Communicable Diseases; Disabled Persons; Global Burden of Disease; Global Health; Noncommunicable Diseases; Wounds and Injuries; Medicine (all); General Medicine
Abstract :
[en] [en] BACKGROUND: As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016.
METHODS: We estimated prevalence and incidence for 328 diseases and injuries and 2982 sequelae, their non-fatal consequences. We used DisMod-MR 2.1, a Bayesian meta-regression tool, as the main method of estimation, ensuring consistency between incidence, prevalence, remission, and cause of death rates for each condition. For some causes, we used alternative modelling strategies if incidence or prevalence needed to be derived from other data. YLDs were estimated as the product of prevalence and a disability weight for all mutually exclusive sequelae, corrected for comorbidity and aggregated to cause level. We updated the Socio-demographic Index (SDI), a summary indicator of income per capita, years of schooling, and total fertility rate. GBD 2016 complies with the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER).
FINDINGS: Globally, low back pain, migraine, age-related and other hearing loss, iron-deficiency anaemia, and major depressive disorder were the five leading causes of YLDs in 2016, contributing 57·6 million (95% uncertainty interval [UI] 40·8-75·9 million [7·2%, 6·0-8·3]), 45·1 million (29·0-62·8 million [5·6%, 4·0-7·2]), 36·3 million (25·3-50·9 million [4·5%, 3·8-5·3]), 34·7 million (23·0-49·6 million [4·3%, 3·5-5·2]), and 34·1 million (23·5-46·0 million [4·2%, 3·2-5·3]) of total YLDs, respectively. Age-standardised rates of YLDs for all causes combined decreased between 1990 and 2016 by 2·7% (95% UI 2·3-3·1). Despite mostly stagnant age-standardised rates, the absolute number of YLDs from non-communicable diseases has been growing rapidly across all SDI quintiles, partly because of population growth, but also the ageing of populations. The largest absolute increases in total numbers of YLDs globally were between the ages of 40 and 69 years. Age-standardised YLD rates for all conditions combined were 10·4% (95% UI 9·0-11·8) higher in women than in men. Iron-deficiency anaemia, migraine, Alzheimer's disease and other dementias, major depressive disorder, anxiety, and all musculoskeletal disorders apart from gout were the main conditions contributing to higher YLD rates in women. Men had higher age-standardised rates of substance use disorders, diabetes, cardiovascular diseases, cancers, and all injuries apart from sexual violence. Globally, we noted much less geographical variation in disability than has been documented for premature mortality. In 2016, there was a less than two times difference in age-standardised YLD rates for all causes between the location with the lowest rate (China, 9201 YLDs per 100 000, 95% UI 6862-11943) and highest rate (Yemen, 14 774 YLDs per 100 000, 11 018-19 228).
INTERPRETATION: The decrease in death rates since 1990 for most causes has not been matched by a similar decline in age-standardised YLD rates. For many large causes, YLD rates have either been stagnant or have increased for some causes, such as diabetes. As populations are ageing, and the prevalence of disabling disease generally increases steeply with age, health systems will face increasing demand for services that are generally costlier than the interventions that have led to declines in mortality in childhood or for the major causes of mortality in adults. Up-to-date information about the trends of disease and how this varies between countries is essential to plan for an adequate health-system response.
FUNDING: Bill & Melinda Gates Foundation, and the National Institute on Aging and the National Institute of Mental Health of the National Institutes of Health.
Disciplines :
Public health, health care sciences & services
Author, co-author :
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators
Khosravi, Mohammadhossein ; Université de Liège - ULiège > GIGA > GIGA Consciousness - Coma Science Group
Language :
English
Title :
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
EU - European Union [BE] UMich - University of Michigan [US-MI] NICHD - National Institutes of Health. Eunice Kennedy Shriver National Institute of Child Health and Human Development [US-MD] NIA - National Institute on Aging [US-MD] BMBF - Bundesministerium für Bildung und Forschung [DE] NHLBI - National Heart Lung and Blood Institute [US-MD] MPG - Max-Planck-Gesellschaft zur Förderung der Wissenschaften [DE] BMGF - Bill and Melinda Gates Foundation [US-WA] Yale University [US-CT] NIH - National Institutes of Health [US-MD] NIMH - National Institute of Mental Health [US-MD] SNF - Schweizerischer Nationalfonds zur Förderung der wissenschaftlichen Forschung [CH]
Funding text :
Research reported in this publication was supported by the Bill & Melinda Gates Foundation, the National Institute on Aging of the National Institutes of Health (award P30AG047845), and the National Institute of Mental Health of the National Institutes of Health (award R01MH110163). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Bill & Melinda Gates Foundation or the National Institutes of Health. The Palestinian Central Bureau of Statistics granted the researchers access to relevant data in accordance with license no. SLN2014-3-170, after subjecting data to processing aiming to preserve the confidentiality of individual data in accordance with the General Statistics Law - 2000. The researchers are solely responsible for the conclusions and inferences drawn upon available data. We thank the Russia Longitudinal Monitoring Survey, RLMS-HSE, conducted by the National Research University Higher School of Economics and ZAO “Demoscope” together with Carolina Population Center, University of North Carolina at Chapel Hill and the Institute of Sociology RAS for making these data available. This study has been realized using the data collected by the Swiss Household Panel (SHP), which is based at the Swiss Centre of Expertise in the Social Sciences FORS. The project is financed by the Swiss National Science Foundation. From the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine. This work was supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (Contract No.N01-HC-25195). The HRS (Health and Retirement Study) is sponsored by the National Institute on Aging (grant number NIA U01AG009740) and is conducted by the University of Michigan. This research used data from the National Health Survey 2003 and the National Health Survey 2009-2010. The authors are grateful to the Ministry of Health, Survey copyright owner, allowing them to have the database. All results of the study are those of the author and in no way committed to the Ministry. This research uses data from Add Health, a program project designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris, and funded by a grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 17 other agencies. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Persons interested in obtaining data files from Add Health should contact Add Health, Carolina Population Center, 123 W. Franklin Street, Chapel Hill, NC 27516-2524 ( addhealth@unc.edu ). No direct support was received from grant P01-HD31921 for this analysis. The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. government. HBSC is an international study carried out in collaboration with WHO/EURO. The International Coordinator of the 1997/98, 2001/02, 2005/06 and 2009/10 surveys was Prof. Candace Currie and the Data Bank Manager for the 1997/98 survey was Prof. Bente Wold, whereas for the following survey Prof. Oddrun Samdal was the Databank Manager. A list of principal investigator in each country can be found at http://www.hbsc.org . Data used in the preparation of this article were obtained from the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Database. In 2011, Prize4Life, in collaboration with the Northeast ALS Consortium, and with funding from the ALS Therapy Alliance, formed the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Consortium. The data available in the PRO-ACT Database has been volunteered by PRO-ACT Consortium members. This paper uses data from SHARE Waves 1, 2, 3 (SHARELIFE), 4, 5 and 6 (DOIs: 10.6103/SHARE.w1.600, 10.6103/SHARE.w2.600, 10.6103/SHARE.w3.600, 10.6103/SHARE.w4.600, 10.6103/SHARE.w5.600, 10.6103/SHARE.w6.600), see Börsch-Supan et al. (2013) for methodological details. (1) The SHARE data collection has been primarily funded by the European Commission through FP5 (QLK6-CT-2001-00360), FP6 (SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812) and FP7 (SHARE-PREP: N°211909, SHARE-LEAP: N°227822, SHARE M4: N°261982). Additional funding from the German Ministry of Education and Research, the Max Planck Society for the Advancement of Science, the U.S. National Institute on Aging (U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064, HHSN271201300071C) and from various national funding sources is gratefully acknowledged (see www.share-project.org ). This manuscript is based on data collected and shared by the International Vaccine Institute (IVI). This manuscript was not prepared in collaboration with investigators of IVI and does not necessarily reflect the opinions or views of IVI. The data used in this paper come from the 2009-10 Ghana Socioeconomic Panel Study Survey which is a nationally representative survey of over 5,000 households in Ghana. The survey is a joint effort undertaken by the Institute of Statistical, Social and Economic Research (ISSER) at the University of Ghana, and the Economic Growth Centre (EGC) at Yale University. It was funded by the Economic Growth Center. At the same time, ISSER and the EGC are not responsible for the estimations reported by the analyst(s).
Nino, F, United Nations Sustainable Development Goals. UNDP. http://www.undp.org/content/undp/en/home/sustainable-development-goals.html (accessed March 10, 2017).
Lim, SS, Allen, K, Bhutta, ZA, et al. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet 388 (2016), 1813–1850.
Vos, T, Allen, C, Arora, M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1545–1602.
Kassebaum, NJ, Arora, M, Barber, RM, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1603–1658.
Kissoon, N, Uyeki, TM, Sepsis and the Global Burden of Disease in Children. JAMA Pediatr 170 (2016), 107–108.
Limmathurotsakul, D, Golding, N, Dance, DAB, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nature Microbiology, 1, 2016 nmicrobiol20158.
Vallabhaneni, S, Mody, RK, Walker, T, Chiller, T, The Global Burden of Fungal Diseases. Infect Dis Clin North Am 30 (2016), 1–11.
Vigo, D, Thornicroft, G, Atun, R, Estimating the true global burden of mental illness. Lancet Psychiatry 3 (2016), 171–178.
Holden, BA, Fricke, TR, Wilson, DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology 123 (2016), 1036–1042.
Jackson, T, Thomas, S, Stabile, V, Shotwell, M, Han, X, McQueen, K, A Systematic Review and Meta-Analysis of the Global Burden of Chronic Pain Without Clear Etiology in Low- and Middle-Income Countries: Trends in Heterogeneous Data and a Proposal for New Assessment Methods. Anesth Analg 123 (2016), 739–748.
Chavan, BS, Aneja, J, Global mental health movement has not helped in reducing global burden of psychiatric disorders. Indian JSoc Psychiatry 32 (2016), 261–266.
Neethling, I, Jelsma, J, Ramma, L, Schneider, H, Bradshaw, D, Disability weights from a household survey in a low socio-economic setting: how does it compare to the global burden of disease 2010 study?. Global Health Action, 9, 2016, 31754.
Jager, KJ, Fraser, SDS, The ascending rank of chronic kidney disease in the global burden of disease study. Nephrol Dial Transplant 32 (2017), ii121–ii128.
Jin, LJ, Lamster, IB, Greenspan, JS, Pitts, NB, Scully, C, Warnakulasuriya, S, Global burden of oral diseases: emerging concepts, management and interplay with systemic health. Oral Diseases 22 (2016), 609–619.
Kwan, GF, Mayosi, BM, Mocumbi, AO, et al. Endemic Cardiovascular Diseases of the Poorest Billion. Circulation 133 (2016), 2561–2575.
Flaxman, AD, Vos, T, Murray, CJL, (eds.) An Integrative Metaregression Framework for Descriptive Epidemiology, 1st edn., 2015, University of Washington Press, Seattle.
Stevens, GA, Alkema, L, Black, RE, et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet 388 (2016), e19–e23.
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 (2017), 1151–1210.
National Tuberculosis Institute. Tuberculosis in a rural population of South India: a five-year epidemiological study. Bull World Health Organ 51 (1974), 473–488.
Mesfin, YM, Hailemariam, D, Biadglign, S, Kibret, KT, Association between HIV/AIDS and Multi-Drug Resistance Tuberculosis: A Systematic Review and Meta-Analysis. PLoS One, 9, 2014, e82235.
Banks, JL, Marotta, CA, Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 38 (2007), 1091–1096.
GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 (2017), 1084–1150.
Agency for Healthcare Research and Quality. United States Medical Expenditure Panel Survey. Rockville, USA: Agency for Health Care Research and Quality.
McKee, S, Rethinking Development and Health: Findings from the Global Burden of Disease Study, 2016, Institute for Health Metrics and Evaluation, Seattle, Washington, USA http://www.healthdata.org/sites/default/files/files/policy_report/GBD/2016/IHME_GBD2015_report.pdf (accessed June 1, 2017).
Tsang, A, Von Korff, M, Lee, S, et al. Common Chronic Pain Conditions in Developed and Developing Countries: Gender and Age Differences and Comorbidity With Depression-Anxiety Disorders. J Pain 9 (2008), 883–891.
Parker, G, Cheah, Y-C, Roy, K, Do the Chinese somatize depression? A cross-cultural study. Soc Psychiatry Psychiatr Epidemiol 36 (2001), 287–293.
Tung, W-C, Li, Z, Pain Beliefs and Behaviors Among Chinese. Home Health Care Management & Practice 27 (2015), 95–97.
Anand, A, Understanding Depression among Older Adults in Six Low-Middle Income Countries using WHO-SAGE Survey. http://jghcs.info/index.php/bh/article/view/363 (accessed July 17, 2017).
Phillips, MR, Zhang, J, Shi, Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey. Lancet 373 (2009), 2041–2053.
WHO. Antimicrobial resistance: global report on surveillance, 2014, 2014, World Health Organization, Geneva, Switzerland.
Spellberg, B, Bartlett, JG, Gilbert, DN, The Future of Antibiotics and Resistance. N Engl J Med 368 (2013), 299–302.
Burnham, G, Doocy, S, Dzeng, E, Lafta, R, Roberts, L, The Human Cost of the War in Iraq. A Mortality Study, 2002–2006, 2016, Bloomberg School of Public Health, Johns Hopkins University; School of Medicine, Al Mustansiriya University; Center for International Studies, Massachusetts Institute of Technology, Baltimore, MD; Baghdad, Iraq; Cambridge, MA.
McMichael, AJ, Woodruff, RE, Hales, S, Climate change and human health: present and future risks. Lancet 367 (2006), 859–869.
Patz, JA, Campbell-Lendrum, D, Holloway, T, Foley, JA, Impact of regional climate change on human health. Nature 438 (2005), 310–317.
Ramsey, R, Giskes, K, Turrell, G, Gallegos, D, Food insecurity among adults residing in disadvantaged urban areas: potential health and dietary consequences. Public Health Nutr 15 (2012), 227–237.
Hassan, G, Ventevogel, P, Jefee-Bahloul, H, Barkil-Oteo, A, Kirmayer, LJ, Mental health and psychosocial wellbeing of Syrians affected by armed conflict. Epidemiol Psychiatr Sci 25 (2016), 129–141.
Rapid Assessment of Avoidable Blideness Repository. RAAB Repository. http://raabdata.info/repository/ (accessed July 17, 2017).
Brooker, S, Hotez, PJ, Bundy, DAP, The Global Atlas of Helminth Infection: Mapping the Way Forward in Neglected Tropical Disease Control. PLOS Neglected Tropical Diseases, 4, 2010, e779.
WHO. Guidelines on the management of latent tuberculosis infection, 2015, World Health Organization, Geneva, Switzerland http://www.who.int/tb/publications/latent-tuberculosis-infection/en/ (accessed May 3, 2017).
Patel, V, Chisholm, D, Parikh, R, et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet 387 (2016), 1672–1685.
Afshin, A, Forouzanfar, MH, Reitsma, M, Sur, P, Estep, K, Murray, CJ, Obesity and overweight and their health impact 1990-2015 in 195 countries. N Engl J Med 377 (2017), 13–27.
Dieleman, JL, Baral, R, Birger, M, et al. US Spending on Personal Health Care and Public Health, 1996-2013. JAMA 316 (2016), 2627–2646.
WHO. Global Tuberculosis Report 2016, 2016, World Health Organization, Geneva, Switzerland.
WHO. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis, 2014, World Health Organization, Geneva, Switzerland.
National AIDS and STI Control Programme (NASCOP). Kenya AIDS Indicator Survey 2012: Final Report, 2014, NASCOP, Nairobi, Kenya.
Ministry of Health, ICF International, Centers for Disease Control and Prevention, U.S. Agency for International Development, and WHO Uganda. Uganda AIDS Indicator Survey, 2012, Ministry of Health, Kampala, Uganda.
UNAIDS. Global AIDS update 2016. 2016; published online May 31. http://www.unaids.org/en/resources/documents/2016/Global-AIDS-update-2016 (accessed March 10, 2017).
International Agency for Research on Cancer. Globocan 2012: Estimated Cancer Incidence, Mortality, and Prevlance Worldwide in 2012, 2017, World Health Organization, Geneva.
WHO. Fifth meeting of the Emergency Committee under the International Health Regulations (2005) regarding microcephaly, other neurological disorders and Zika virus. http://www.who.int/mediacentre/news/statements/2016/zika-fifth-ec/en/ (accessed July 6, 2017).
Barry, M, The tail end of guinea worm: global eradication without a drug or a vaccine. N Engl J Med 356 (2007), 2561–2564.
GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 (2017), 1345–1359.
Jensen, ET, Cook, SF, Allen, JK, et al. Enrollment factors and bias of disease prevalence estimates in administrative claims data. Ann Epidemiol 25 (2015), 519–525.e2.
Kottke, TE, Baechler, CJ, Parker, ED, Accuracy of Heart Disease Prevalence Estimated from Claims Data Compared With an Electronic Health Record. Prev Chronic Dis, 9, 2012 DOI:10.5888/pcd9.120009.
Rothberg, MB, Pekow, PS, Priya, A, Lindenauer, PK, Variation in Diagnostic Coding of Patients With Pneumonia and Its Association With Hospital Risk-Standardized Mortality Rates: A Cross-sectional Analysis. Ann Intern Med 160 (2014), 380–388.
Yeom, H, Kang, DR, Cho, SK, Lee, SW, Shin, D-H, Kim, HC, Admission route and use of invasive procedures during hospitalization for acute myocardial infarction: analysis of 2007-2011 National Health Insurance database. Epidemiol Health, 37, 2015, e2015022.
Ghosh, A, McCarthy, S, Halcomb, E, Perceptions of primary care staff on a regional data quality intervention in Australian general practice: a qualitative study. BMC Fam Pract, 17, 2016, 50.
Pooled Resource Open-Access ALS Clinical Trials Database. PRO-ACT - Data Sets. https://nctu.partners.org/ProACT/Data/Index/ (accessed May 3, 2017).
Barber, RM, Fullman, N, Sorensen, RJD, et al. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet 390 (2017), 231–266.
